Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis

被引:155
作者
Foj, Laura [1 ]
Ferrer, Ferran [2 ]
Serra, Marta [3 ]
Arevalo, Antonio [3 ]
Gavagnach, Montserrat [3 ]
Gimenez, Nuria [4 ]
Filella, Xavier [1 ]
机构
[1] IDIBAPS, Hosp Clin, Dept Biochem & Mol Genet CDB, C Villarroel 170, Barcelona 08036, Catalonia, Spain
[2] Univ Barcelona, Hosp Llobregat, IDIBELL,Dept Radiotherapy, Inst Catala Oncol,Dept Clin Sci Bellvitge Hlth Sc, Barcelona, Catalonia, Spain
[3] CAP Valldoreix, Sant Cugat Del Valles, Catalonia, Spain
[4] Fundacio Recerca Mutua Terrassa, Terrassa, Catalonia, Spain
关键词
prostate cancer; miRNA; exosomes; urine; CIRCULATING MICRORNAS; RADICAL PROSTATECTOMY; DOWN-REGULATION; EXPRESSION; BIOMARKERS; TARGETS; MARKERS; INVASION; GROWTH; TISSUE;
D O I
10.1002/pros.23295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDMicroRNAs (miRNAs) are non-coding small RNAs, involved in post-transcriptional regulation of many target genes. METHODSFive miRNAs that have been consistently found deregulated in PCa (miR-21, miR-141, miR-214, miR-375, and let-7c) were analyzed in urinary pellets from 60 prostate cancer (PCa) patients and 10 healthy subjects by qRT-PCR. Besides, urinary exosomes were isolated by differential centrifugation and analyzed for those miRNAs. RESULTSSignificant upregulation of miR-21, miR-141, and miR-375 was found comparing PCa patients with healthy subjects in urinary pellets, while miR-214 was found significantly downregulated. Regarding urinary exosomes, miR-21 and miR-375 were also significantly upregulated in PCa but no differences were found for miR-141. Significant differences were found for let-7c in PCa in urinary exosomes while no differences were observed in urinary pellets. A panel combining miR-21 and miR-375 is suggested as the best combination to distinguish PCa patients and healthy subjects, with an AUC of 0.872. Furthermore, the association of miRNAs with clinicopathological characteristics was investigated. MiR-141 resulted significantly correlated with Gleason score in urinary pellets and let-7c with clinical stage in urinary exosomes. Additionally, miR-21, miR-141, and miR-214 were found significantly deregulated in intermediate/high-risk PCa versus low-risk/healthy subjects in urinary pellets. Significant differences between both groups were found in urinary exosomes for miR-21, miR-375, and let-7c. CONCLUSIONSThese findings suggest that the analysis of miRNAsespecially miRNA-21 and miR-375- in urine could be useful as biomarkers in PCa. Prostate 77: 573-583, 2017. (c) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:573 / 583
页数:11
相关论文
共 51 条
[1]   Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer [J].
Agaoglu, Fulya Yaman ;
Kovancilar, Muge ;
Dizdar, Yavuz ;
Darendeliler, Emin ;
Holdenrieder, Stefan ;
Dalay, Nejat ;
Gezer, Ugur .
TUMOR BIOLOGY, 2011, 32 (03) :583-588
[2]  
[Anonymous], 2011, REV MEX UROL
[3]   Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy [J].
Boorjian, Stephen A. ;
Karnes, R. Jeffrey ;
Rangel, Laureano J. ;
Bergstralh, Eric J. ;
Blute, Michael L. .
JOURNAL OF UROLOGY, 2008, 179 (04) :1354-1360
[4]   Changes in circulating microRNA levels associated with prostate cancer [J].
Bryant, R. J. ;
Pawlowski, T. ;
Catto, J. W. F. ;
Marsden, G. ;
Vessella, R. L. ;
Rhees, B. ;
Kuslich, C. ;
Visakorpi, T. ;
Hamdy, F. C. .
BRITISH JOURNAL OF CANCER, 2012, 106 (04) :768-774
[5]   Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients [J].
Bryzgunova, Olga E. ;
Zaripov, Marat M. ;
Skvortsova, Tatyana E. ;
Lekchnov, Evgeny A. ;
Grigor'eva, Alina E. ;
Zaporozhchenko, Ivan A. ;
Morozkin, Evgeny S. ;
Ryabchikova, Elena I. ;
Yurchenko, Yuri B. ;
Voitsitskiy, Vladimir E. ;
Laktionov, Pavel P. .
PLOS ONE, 2016, 11 (06)
[6]   Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer? [J].
Carter, H. Ballentine ;
Partin, Alan W. ;
Walsh, Patrick C. ;
Trock, Bruce J. ;
Veltri, Robert W. ;
Nelson, William G. ;
Coffey, Donald S. ;
Singer, Eric A. ;
Epstein, Jonathan I. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) :4294-4296
[7]   A panel of five circulating microRNAs as potential biomarkers for prostate cancer [J].
Chen, Zhang-Hui ;
Zhang, Guang-Lin ;
Li, Huan-Rong ;
Luo, Jin-Dan ;
Li, Zhong-Xiang ;
Chen, Ge-Ming ;
Yang, Jun .
PROSTATE, 2012, 72 (13) :1443-1452
[8]   Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia [J].
Cheng, Heather H. ;
Mitchell, Patrick S. ;
Kroh, Evan M. ;
Dowell, Alexander E. ;
Chery, Lisly ;
Siddiqui, Javed ;
Nelson, Peter S. ;
Vessella, Robert L. ;
Knudsen, Beatrice S. ;
Chinnaiyan, Arul M. ;
Pienta, Kenneth J. ;
Morrissey, Colm ;
Tewari, Muneesh .
PLOS ONE, 2013, 8 (07)
[9]   BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition [J].
Coppola, V. ;
Musumeci, M. ;
Patrizii, M. ;
Cannistraci, A. ;
Addario, A. ;
Maugeri-Sacca, M. ;
Biffoni, M. ;
Francescangeli, F. ;
Cordenonsi, M. ;
Piccolo, S. ;
Memeo, L. ;
Pagliuca, A. ;
Muto, G. ;
Zeuner, A. ;
De Maria, R. ;
Bonci, D. .
ONCOGENE, 2013, 32 (14) :1843-1853
[10]   Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Fondurulia, J ;
Chen, MH ;
Tomaszewski, JE ;
Renshaw, AA ;
Wein, A ;
Richie, JP .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1164-1172